Sort
82,697 grants matching “vaccine development”
DNA Sequencing and FACS Core Facilities
$1,570,280Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Allergen and T-Cell Reagent Resources for the Study of Allergic Diseases
$1,570,179Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2011 · AI
DNA Vaccines
$1,570,101George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
$1,570,047Dana Borden Lacy · Vanderbilt University Medical Center · U19 · FY2025 · AI
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
$1,570,047Dana Borden Lacy · Vanderbilt University Medical Center · U19 · FY2023 · AI
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
$1,570,047Dana Borden Lacy · Vanderbilt University Medical Center · U19 · FY2024 · AI
DNA Vaccine for Induction of Mucosal Immunity
$1,569,914David B. Weiner · University Of Pennsylvania · P01 · FY2008 · AI
NINDS Cooperative Program in Translational Research
$1,569,553Mary P Stenzel-Poore · Oregon Health & Science University · U01 · FY2012 · NS
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors
$1,569,436Alan Thomas Johnson · Hawaii Biotech, Inc. · R01 · FY2016 · AI
Research to control and eliminate malaria in SE Asia and SW Pacific
$1,569,425James Walter Kazura · Case Western Reserve University · U19 · FY2014 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients
$1,569,278Elaine F Reed · University Of California Los Angeles · U19 · FY2017 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients
$1,569,278Elaine F Reed · University Of California Los Angeles · U19 · FY2018 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients
$1,569,278Elaine F Reed · University Of California Los Angeles · U19 · FY2020 · AI
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,569,064Elizabeth A Klonoff · San Diego State University · U54 · FY2010 · CA
Penn prevention clinical trials unit
$1,568,547David S Metzger · University Of Pennsylvania · U01 · FY2008 · AI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,568,472Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Tuberculosis Research Unit
$1,567,641W. Henry Henry Boom · Case Western Reserve University · N01 · FY2010 · AI
HIV Preventive Vaccine Studies
$1,567,389Barney Scott Graham · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$1,566,975Johns Hopkins University · U01 · FY2005 · AI
Advanced Development of Vaccines for Infectious Diseases
$1,566,580Neal Van Hoeven · Access To Advanced Health Institute · N01 · FY2019 · AI
Advanced Development of Vaccines for Infectious Diseases
$1,566,579Neal Van Hoeven · Access To Advanced Health Institute · N01 · FY2019 · AI
Cell Type-specific Anterograde Circuit Mapping and Functional Control by Optimizing YFV-17D Transneuronal Systems
$1,566,333Wei Xu · Ut Southwestern Medical Center · RF1 · FY2022 · MH
Strategies for Cancer Immunotherapy Clinical Trials
$1,566,117Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,566,117Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Scanning B. pseudomallei proteome for vaccine antigens
$1,566,070University Of California Irvine · U01 · FY2004 · AI